Chondroitin sulfate (CS) proteoglycans are present on the surfaces of virtually all cells and in the extracellular matrix and are required for cytokinesis at early developmental stages. Studies have shown that heparan sulfate (HS) is essential for maintaining mouse embryonic stem cells (ESCs) that are primed for differentiation, whereas the function of CS has not yet been elucidated. To clarify the role of CS, we generated glucuronyltransferase-I-knockout ESCs lacking CS. We found that CS was required to maintain the pluripotency of ESCs and promoted initial ESC commitment to differentiation compared with HS. In addition, CS-A and CS-E polysaccharides, but not CS-C polysaccharides, bound to E-cadherin and enhanced ESC differentiation. Multiple-lineage differentiation was inhibited in chondroitinase ABC-digested wild-type ESCs. Collectively, these results suggest that CS is a novel determinant in controlling the functional integrity of ESCs via binding to E-cadherin. E mbryonic stem cells (ESCs) are pluripotent cells derived from the inner cell mass of the blastocyst-stage embryo 1,2 . In vitro differentiation by formation of free-floating aggregates of ESCs, called embryoid bodies (EBs), is often used for derivation of all three germ layers and can mimic early post-implantation embryonic development 3 . Differentiation and fate commitment of ESCs derived from EBs are controlled by the interaction of the cells with their surrounding microenvironment, of which the extracellular matrix (ECM) is one of the main components. E-cadherin, a major component of the ECM of ESCs, is a cytosolic adaptor that links tight junction transmembrane proteins to the actin cytoskeleton 4,5 . E-cadherin has been implicated in the regulation of signaling pathway hierarchy in ESCs 6,7 and in enhanced induced pluripotent stem (iPS) cell generation [8] [9] [10] .
with chondroitinase ABC (CSase) die in the two-to eight-cell stage, whereas many heparitinase-treated embryos develop normally to blastocysts. Consequently, we concluded that CS is indispensable for early embryonic cell division in mammals. Notably, from heterozygous intercrossed embryos, 7% of homozygous GlcAT-I 2/2 embryos could be identified at the implantation stages 25 . In the current study, we established GlcAT-I-deficient mouse ESCs (mESCs), to determine the role of CS in mESC self-renewal and differentiation. Our results suggest that CS is crucial for the maintenance of ESC pluripotency and differentiation through interactions with Ecadherin.
Results
GlcAT-I knockout ESCs completely lack CS and HS and fail to initiate differentiation and form EBs. Homozygous GlcAT-I 2/2 ESCs were established from heterozygous intercrosses. The quantities of CS and HS isolated from GlcAT-I 1/1 , GlcAT-I 1/2 , and GlcAT-I 2/2 ESCs were analyzed and measured with high-performance liquid chromatography. CS and HS were completely absent in Glc-AT-I 2/2 ESCs (Table 1 and Supplementary Table S1 ). Alkaline phosphatase assays performed to measure self-renewal of these cells showed that the level of self-renewal in GlcAT-I 2/2 ESCs was comparable to that of GlcAT-I 1/2 and GlcAT-I 1/1 ESCs in the presence of Leukemia inhibitory factor (LIF) ( Fig. 1A and B ). Realtime RT-PCR and western blot analyses showed increased mRNA and protein expression of two pluripotency genes, Nanog and Sox2, in GlcAT-I 2/2 ESCs compared with GlcAT-I 1/2 and GlcAT-I 1/1 ESCs (Fig. 1C and D) .
To further explore the role of GAGs in self-renewal, GlcAT-I 1/1 , GlcAT-I 1/2 , and GlcAT-I 2/2 ESCs were cultured in the absence of LIF. A high percentage of GlcAT-I 2/2 cell colonies remained alkaline phosphatase-positive even in the absence of LIF, showing that Glc-AT-I 2/2 ESCs were unable to exit the self-renewal program ( Fig. 2A  and B ). In addition, GlcAT-I 2/2 ESCs retained high expression of Nanog, Oct3/4, and Sox2 (Fig. 2C , D and E).
Next, to verify that GAGs are required for cell fate commitment into multiple lineages, ESCs were differentiated into EBs. GlcAT-I 2/2 ESCs cultured in static suspension culture exhibited weaker cell-cell interactions than GlcAT-I 1/2 and GlcAT-I 1/1 EBs and failed to establish characteristic EB morphological features compared to GlcAT-I 1/2 and GlcAT-I 1/1 EBs (Fig. 3A) . These results appear to be similar to those from EBs that are deficient in HS synthesis (Ext1 2/2 ) 31 . During EB differentiation, primitive endodermal (PE) cells develop into the outermost cell layer, similar to the PE cells segregating from the inner cell mass, forming an epithelial layer toward the blastocoel cavity 34 . Upon differentiation of GlcAT-I 1/1 and GlcAT-I 1/2 to EBs, markers of the extraembryonic endoderm (Gata4), early mesoderm (Tbx6, Foxc1, and Brachyury), and ectoderm (Nestin) lineages were upregulated concomitantly with a decline in the transcript and protein levels of pluripotency genes such as Nanog and Oct4 (Fig. 3B , C and D, and also see Supplementary Fig. S1A ). In contrast, GlcAT-I 2/2 EBs retained high expression levels of Nanog and Oct4, and lineage markers were undetectable ( Fig. 3B , C and D, and also see Supplementary Fig. S1A ), indicating that GlcAT-I 2/2 ESCs failed to differentiate into multiple lineages.
The sulfation pattern of CS regulates EB differentiation. If CS is indispensable for cell fate commitment and cell-cell interactions in EBs, digestion of CS on wild-type (Wt) ES cells may also influence EB formation. In fact, treatment of Wt ESCs with CSase had marked effects on EB formation, although heparitinase-treated ESCs seemed to develop normally to EBs (Fig. 4A , C and D, and Supplementary  Fig. S1B ), indicating that CS chains on the cell surface were involved in EB differentiation. The complete and selective digestion of GAG chains was confirmed by immunofluorence image using anti-CS (LY111) or anti-HS (Hepss-1) monoclonal antibodies ( Fig. 4B ). Next, to investigate the importance of specific sulfation sequences on CS chains in ESC differentiation, the CS disaccharide composition was analyzed during the differentiation of ESCs into EBs. Differentiating EBs exhibited an increase in the total content of CS disaccharides over time ( Supplementary Table S2 ). Additionally, although the amount of DHexA-GalNAc(4-O-sulfate, 6-O-sulfate) (CS-E-unit) and DHexA-GalNAc(4-O-sulfate) (CS-A-unit) markedly increased, that of DHexA-GalNAc and DHexA-GalNAc(6-Osulfate) (CS-C-unit) decreased slightly as differentiation progressed ( Supplementary Table S2 ). These results suggest that CS-A and CS-E chains may be important for EB differentiation. Thus, to confirm the role of CS in EB differentiation, additional analyses of GlcAT-I 2/2 ES cells cultured in the presence of CS-A, CS-C, CS-E, or Hep polysaccharides were performed. As shown in Fig. 4E and Supplementary  Fig. S2A and C, addition of CS-A or CS-E polysaccharides restored the EB size and proliferative capacity, whereas addition of CS-C or Hep did not. Furthermore, addition of CS-A or CS-E polysaccharides to GlcAT-I 2/2 EB cultures rescued the differentiation of these cells into PE (Fig. 4E , F and G and Supplementary Fig. S1A ). These results indicate that CS-A and CS-E may be essential factors in EB formation.
E-cadherin interacts directly with CS-A and CS-E.
We have recently demonstrated that CS-E fine-tunes osteoblast differentiation via extracellular signaling-regulated kinase (ERK)1/2, Smad3, and Smad 1/5/8 signaling by binding to N-cadherin and cadherin-11 35 . In fact, CS-E interacts with N-cadherin and cadherin-11 through calcium-dependent adhesion, whereas CS-A does not. In addition, E-cadherin-null ESCs fail to form EBs and remain undifferentiated even in the absence of LIF 7 . Therefore, we hypothesized that interaction between CS with a specific structure such as CS-A or CS-E and E-cadherin is required for EB formation and differentiation. Thus, the interaction of various CSs and E-cadherin was examined using the surface plasmon resonance biosensor, BIAcore. As shown in Fig. 5A and Supplementary Table S3 , the CS-E polysaccharide bound strongly to E-cadherin only in the presence of calcium. In addition, CS-A also bound to E-cadherin only in the presence of calcium, whereas CS-C polysaccharide did not. Thus, CS-A and CS-E interacted with E-cadherin in a calcium-dependent manner.
We next examined whether CS colocalized with E-cadherin in ESCs. Double immunostaining of Wt ESCs using anti-CS (LY111) or anti-HS (Hepss-1) monoclonal antibodies and anti-E-cadherin was carried out. CS colocalized with E-cadherin on the cell surface and in the intercellular junctions ( Fig. 5B ), whereas HS was localized diffusely on the cell surface and was partially colocalized with Ecadherin ( Fig. 5C ). Using a neutralizing antibody against E-cadherin, we further analyzed whether the effect of exogenous CS-A or CS-E on EB formation was dependent on E-cadherin. Addition of CS-A in the presence of anti-E-cadherin antibody (E-cad Ab) did not restore EB size ( Fig. 6A and B) or the proliferative capacity ( Supplementary Fig. S2C ) and did not induce ESC differentiation into the PE layer ( Fig. 6C and D) . In addition, treatment of GlcAT-I 2/2 ES cells with both anti-E-cadherin antibody and CS-E failed to establish characteristic EB morphology and cell proliferation ( Supplementary Fig. S2B and C) . In contrast, treatment of GlcAT-I 2/2 ES cells with only anti-E-cadherin antibody had no effect on EB size or proliferative capacity compared with untreated GlcAT-I 2/2 ES cells ( Supplementary Fig. S2B and C). These results indicated that CS chains are involved in controlling initial differentiation of ESCs by binding to E-cadherin. Of note, Ecadherin expression was increased in GlcAT-I 2/2 ES cells compared with GlcAT-I 1/1 ES cells ( Supplementary Fig. S3 ). Consistent with this, the cell attachment rate was about 2-fold higher in GlcAT-I 2/2 ES cells compared with wild-type ES cells, indicating that the adhesive function of E-cadherin was not disrupted in GlcAT-I 2/2 ES cells ( Supplementary Fig. S4 ). Taken together, the data suggest that CS-A and CS-E are selective ligands for a potential CS receptor, E-cadherin, leading to ES cell differentiation. Rho-Rock signaling is attenuated in GlcAT-I 2/2 ESCs. In ES cells, both E-cadherin and ECM signals can regulate Rho activity 36 . Endogenous Rho signaling is required for the maintenance of cellcell contact in ESCs, and the level of active RhoA decreases in response to E-cadherin-mediated adhesion. In addition, upregulation of active RhoA increases ERK1/2 phosphorylation 37 . Therefore, intracellular signaling pathways were further analyzed to determine whether CS chains regulate ESC differentiation by binding to Ecadherin.
As shown in Fig. 6E and F, ESCs treated with CSase indeed exhibited a decrease in active RhoA and ERK1/2 phosphorylation. In GlcAT-I 2/2 ESCs, the levels of active RhoA and ERK1/2 phosphorylation were reduced, whereas the levels of active RhoA and ERK1/2 phosphorylation were rescued when GlcAT-I 2/2 ESCs were cultured in the presence of CS-A or CS-E, but not CS-C ( Fig. 6E and F) . In contrast, treatment of GlcAT-I 2/2 ES cells with anti-E-cadherin Ab in the presence of CS-A failed to increase active RhoA and ERK1/2 phosphorylation. In addition, treatment of GlcAT-I 2/2 ES cells with C3 transferase, which inactivates Rho proteins by ADP-ribosylation without affecting other Rho GTPases such as Cdc42 and Rac 38 , in the presence of CS-A failed to increase active RhoA. These results indicate that CS-A and CS-E bound E-cadherin with significant affinity and induced intracellular signaling downstream of E-cadherin.
Discussion
Numerous studies have shown that signaling molecules such as LIF, together with transcription factors such as Nanog, control the native pluripotency of ESCs by protecting ESCs from fibroblast growth factor (FGF)-4-mediated commitment to differentiation 29, [39] [40] [41] [42] . In addition, HS-mediated FGF signaling has recently been shown to be rate limiting for commitment of the PE to the neural lineage 28 . In this study, we investigated the requirement for CS in the specification and maintenance of ESCs by analyzing the consequence of loss of CS in the differentiation of GlcAT-I 2/2 ESCs. GlcAT-I 2/2 ESCs failed to differentiate in vitro and failed to maintain transcriptional and morphological characteristics of ESCs despite culture conditions promoting differentiation. Similarly, addition of CS-A or CS-E to GlcAT-I 2/2 EBs rescued PE differentiation, whereas addition of CS-C, HS, or Hep did not. Thus, our results emphasized the absolute requirement of signaling mediated by CSs with specific structures for the establishment of cell-cell contact-mediated EB differentiation of ESCs, as primitive endoderm-specific markers such as Gata4 were upregulated and pluripotency markers such as Nanog were downregulated in ESCs. In addition, mesodermal and endoderm markers such as Brachyury and FoxA2 were not expressed despite addition of CS-A or CS-E to GlcAT-I 2/2 EBs (data not shown), because the differentiation program could not proceed in the absence of HS-FGF4 signaling 43 . These results clearly indicate that although both CS and HS are important for ES differentiation, the functions of CS are different from those of HS in ESCs.
A recent study demonstrated that E-cadherin knockout ES cells exhibit loss of cell-cell contact and cellular proliferation and maintain an undifferentiated phenotype in the absence of LIF 7 , suggesting that cell-surface E-cadherin positively regulates the differentiation of ESCs. Conversely, enhanced iPS cell generation can be achieved by overexpression of E-cadherin, and knockdown of endogenous Ecadherin or abrogation of cell-cell contact by E-cadherin inhibition results in reduced reprogramming efficiency 8 . In addition, differentiation of ESCs is associated with the downregulation of cell surface Ecadherin 44 , and in a screen for cell adhesion molecules, E-cadherin is upregulated during reprogramming 9 . Moreover, E-cadherin is essential for the maintenance of pluripotency of mESCs 10 . The reasons for these opposite functions in which ES cells exit the proliferative state and show enhanced pluripotency through E-cadherin are unclear. However, the present finding that CS is a novel determinant in controlling the functional integrity of ESCs by binding to E-cadherin can account for the opposite functions of E-cadherin as follows (Fig. 7) . Lack of CS causes abnormal, ubiquitous, and constitutively high expression of Nanog; conversely, addition of CS-A or CS-E to GlcAT-I 2/2 ESCs causes substantial reduction in the expression of Nanog and increased induction of the PE marker Gata4. In addition, the effect of addition of CS-A or CS-E to GlcAT-I 2/2 ESCs was completely blocked by anti-E-cadherin Ab. These data strongly suggest that CS is a novel determinant of the ESC state through its interaction with E-cadherin and that it controls the balance between self-renewal and differentiation. We propose that interaction between CS and E-cadherin stimulates the tendency of ESCs to differentiate by counterbalancing signaling pathways and transcription factors that promote native pluripotency. However, homophilically interacting E-cadherin or lack of E-cadherin inhibits the differentiation of ESCs due to the disruption of the binding of CS to E-cadherin (Fig. 7) .
This study also showed that CS binding to E-cadherin promotes ESC differentiation through control of the Rho signaling pathway. Rho signaling is required for the maintenance of cell-cell contacts in mESCs 37 . In addition, inhibition of Rho kinase efficiently improves the derivation of ESCs 45 . When Wt ESCs were treated with CSase, the Nanog expression increased and Rho signaling was downregulated, compared to the findings for untreated Wt ESCs ( Fig. 4C and  Fig. 6E ). In addition, GlcAT-I 2/2 ESCs lacking CS exhibited abnormalities similar to those exhibited by ESCs overexpressing or lacking E-cadherin. Because CS is also important for E-cadherin-mediated reprogramming of ESCs, CSase or an inhibitor of CS biosynthesis may be useful for the culture of ESCs and induction of iPS cells.
Methods
Materials. Proteus vulgaris chondroitinase ABC (CSase; EC 4.2.2.4), Flavobacterium heparinum heparitinase and heparinase, the monoclonal antibodies Hepss-1 and LY111, CS-A from whale cartilage, CS-C from shark cartilage, CS-E from squid cartilage, and HS from bovine kidneys were purchased from Seikagaku Corp. (Tokyo, Japan). The recombinant E-cadherin Fc chimera was purchased from R&D Systems (Minneapolis, MN). Heparin from porcine intestinal mucosa was purchased from Sigma. The anti-E-cadherin (ECCD-1) antibody was purchased from Takara. Antibodies against ERK1/2 and phospho-ERK1/2 were purchased from Cell Signaling Technology (Boston, MA).
Animals. The generation of GlcAT-I 2/2 mice has been reported previously 25 . Mice were kept under pathogen-freeconditions in an environmentally controlled, clean room at the Institute of Laboratory Animals, Kobe Pharmaceutical University; animals were maintained on standard rodent food and on a 12-h light/12-h dark cycle. All experiments were conducted according to the institutional ethical guidelines for animal experiments and safety guidelines for gene manipulation experiments. All animal procedures were approved by the Kobe Pharmaceutical University Committee on Animal Research and Ethics.
Isolation of ESC lines. GlcAT-I 2/2 and GlcAT-I 1/1 ES cells were isolated from the inner cell mass of explanted blastocysts derived from heterozygous intercrosses (GlcAT-I 1/2 3 GlcAT-I 1/2 ). Genotypes were determined with PCR using wild-type allele-specific primers (primers a: 59-CTGAGGATATCCCAGTTGC-39 and b: 59-ACATAGATAGTAGGCAGGGCC-39) or mutant allele-specific primers for the neo gene (primers c: 59-GTTGTCACTGAAGCGGGAAGG-39 and d: 59-GAAGAACTCGTCAAGAAGGCGATAG-39). PCR was carried out with Go-Taq Flexi DNA polymerase (Promega, Madison, WI) for 30 cycles at 96uC for 20 s, 56uC for 20 s, and 72uC for 30 s.
ESC culture. ESCs were maintained on a monolayer of mitomycin-C-inactivated mouse fibroblasts in the presence of knockout DMEM supplemented with 20% KnockOut TM Serum Replacement, 100 mM 2-mercaptoethanol, MEM non-essential amino acids, 2 mM L-glutamine, 1 mM pyruvate, and 100 U/ml LIF ESGRO (Millipore). The medium was changed every day, and ES cells were passaged every second day.
Analyses of the disaccharide composition of GAGs. GAGs from feeder-free ES cells were prepared as described previously 17 . The purified GAG fraction was digested with CSase or a mixture of heparinase and heparitinase, and the digests were then derivatized with 2-aminobenzamide and analyzed with high-performance liquid chromatography as described 17 .
In vitro differentiation of ES cells. Before beginning differentiation experiments, the ES cell cultures were depleted of feeder cells by incubating trypsinized cells in ES cell medium on culture dishes for 30 min, during which only the feeder cells attached to www.nature.com/scientificreports SCIENTIFIC REPORTS | 4 : 3701 | DOI: 10.1038/srep03701 the dish. Subsequently, the remnant ES cells were plated on gelatin-coated dishes, cultured overnight, and feeder-depleted again before they were counted and plated according to the various differentiation protocols. Differentiation in adherent monolayer culture was achieved in 20% KnockOut TM Serum Replacement without LIF. For differentiation into EBs, ESCs were transferred into bacterial dishes at 5000 cells/ml in 20% KnockOut TM Serum Replacement without LIF. Differentiating EBs and ESCs were exposed to CS-A, CS-C, CS-E, Hep, or HS. For size analysis, mean diameters were measured using morphological analysis software (Mac SCOPE; Mitani Corp., Tokyo, Japan) and calculated from more than five sample EBs per field in 10 fields. At least 300 EBs were analyzed for each sample.
Self-renewal assay. ES cells were seeded at clonal density and cultured for 5 d in ES medium with or without LIF. The culture medium was removed, and the cells were washed with phosphate-buffered saline (PBS) and tested for alkaline phosphatase activity using an alkaline phosphatase kit (Millipore). One hundred colonies were scored, and the percentage of AP-positive colonies was calculated. Dome-shaped colonies with tightly packed AP-positive cells were considered undifferentiated. Colonies with a mixture of stained and unstained colonies and with flattened and non-uniform morphology were considered differentiated 31 .
Immunofluorescence. For immunofluorescence, cells were fixed in 4% paraformaldehyde for 10 min and blocked in 3% BSA for 60 min, with PBS washes between all steps. For whole-mount EB immunofluorescence, EBs after treatment with CSase or HSase were washed in PBS, fixed for 1 h in 4% PFA at 4uC and washed three times with wash buffer (150 mM NaCl, 1 mg/ml BSA, 0.1% Tween-20, 50 mM Tris-HCl pH 7.5). EBs were permeabilized for 30 min in 2% TritonX-100, refixed in 4% PFA for 20 min, and then blocked in wash buffer for 2 h 46 . Antibodies were diluted in blocking solution. The primary antibodies and the corresponding dilutions used in this study were Hepss-1 (151000; Seikagaku Corp.), LY111 (15500; Seikagaku Corp.), Oct3/4 (sc-5279, 15200; Santa Cruz Biotechnology, Inc.), Nanog (15500; ReproCell), SOX2 (#245610, 15150, R&D Systems), and E-cadherin (ECDD-2, 15100; Takara). Appropriate secondary antibodies (Alexa488-conjugated 15200, Alexa568-conjugated 15200) were obtained from Invitrogen. To visualize nuclei, cells were incubated in DAPI (Dojindo) for 10 min at room temperature. Fluorescent images were obtained using a laser-scanning confocal microscope LSM710 (Carl Zeiss).
Rho activation assay. Rho activity was determined by measuring RhoA-GTP binding to the glutathione S-transferase-RhoA-binding domain in a pull-down assay using a Rho assay reagent (Upstate) according to the manufacturer's instructions.
Protein extraction and western blot analysis. Cells were lysed with immunoprecipitation buffer containing 0.5 mM phenylmethylsulfonyl fluoride, complete protease inhibitor mixture (Roche), 1% Triton X-100, and 1 mM sodium orthovanadate. Cell lysates were centrifuged at 12,000 3 g for 20 min at 4uC, and the supernatants were stored at 280uC. Protein quantification was performed using the bicinchoninic acid protein assay reagent (Pierce). Protein aliquots (3 mg) were denatured in SDS sample buffer and electrophoresed on 10% polyacrylamide-SDS gels. The membranes were immunoblotted using a primary antibody against SOX2 (#245610, 151000, R&D Systems), Gata4 (15200; H-112, Santa Cruz Biotechnology, Inc.), Oct3/4 (sc-5279, 15200; Santa Cruz Biotechnology, Inc.), Nanog (151000; ReproCell), RhoA (15200; Santa Cruz Biotechnology, Inc.), ERK1/2 (#9102, 15200; Cell Signaling), phospho-ERK1/2 (#9101, 15200; Cell Signaling), and b-actin (151000; Sigma). The antigen-antibody complexes were visualized using appropriate secondary antibodies (Sigma) and the enhanced chemiluminescence detection system, as recommended by the manufacturer (GE Healthcare).
ES cell culture with CSase or HSase. Before beginning differentiation experiments, the ES cell cultures were depleted of feeder cells by incubating trypsinized cells in ES cell medium on culture dishes for 30 min, during which only the feeder cells attached to the dish. Subsequently, the remnant ES cells were plated on gelatin-coated dishes, cultured overnight, and feeder-depleted again in ES cell medium with the addition of CSase (10 mIU) or HSase (Heparinase and heparitinase, 5 mIU each) on culture dishes for 60 min before they were counted. ESCs were transferred into bacterial dishes at 5000 cells/ml in 20% KnockOut TM Serum Replacement without LIF and with the addition of CSase (10 mIU) or HSase (Heparinase and heparitinase, 5 mIU each). The medium with CSase or HSase was changed every second day.
Quantitative real-time RT-PCR. Total RNA was extracted from ES cells using TRIzolR reagent (Invitrogen). cDNA was synthesized from 1 mg of total RNA by using Moloney murine leukemia virus reverse transcriptase (Promega) and a random nonamer primer (TaKaRa Bio Inc., Shiga, Japan). The primer sequences were: Nanog, forward primer 59-AGAACAAGGTCCTTGCCA- 39 Interaction analysis. The binding of CS-A, CS-C, or CS-E polysaccharide to Ecadherin was examined using the BIAcore J system (GE Healthcare) as described previously 47 , with slight modifications. Briefly, recombinant E-cadherin-Fc was immobilized on a CM5 sensor chip (GE Healthcare), according to the manufacturer's instructions. A series of CS-A or CS-E concentrations ranging from 20 to 400 nM in running buffer was applied to the flow cells, and changes in resonance units were recorded. Data were analyzed using the BIAevaluation 3.0 software (GE Healthcare) using a 151 Langmuir binding model. Statistical analysis. Student's t-test was used for determination of statistical significance throughout the study. Differences were considered to be significant with a P value less than 0.01.
